Valuation: KMPHARMACEUTICAL Co.,Ltd.

Market Cap 3.89B 2.9M 2.6M 2.4M 2.18M 4.06M 276M 4.11M 28.72M 11.44M 144M 10.87M 10.64M 458M P/E 2024
-20.9x
P/E 2025 -18.9x
Enterprise Value 19.34B 14.39M 12.91M 11.94M 10.81M 20.2M 1.37B 20.44M 143M 56.84M 717M 54M 52.86M 2.28B EV / Sales 2024
2.24x
EV / Sales 2025 1.9x
Free-Float
65.95%
Yield 2024 *
-
Yield 2025 -
08-28 Tranche Update on KMPHARMACEUTICAL Co.,Ltd.'s Equity Buyback Plan announced on July 27, 2026. CI
08-25 KMPHARMACEUTICAL Co.,Ltd.'s Equity Buyback announced on July 27, 2026, has closed with 171,897 shares, representing 0.62% for KRW 300 million. CI
07-27 KMPHARMACEUTICAL Co.,Ltd. announces an Equity Buyback for 207,612 shares, for KRW 300 million. CI
07-26 Km Pharmaceutical Co., Ltd. authorizes a Buyback Plan. CI
07-13 KMPHARMACEUTICAL Co.,Ltd. announced that it expects to receive KRW 999.999765 million in funding CI
03-25 KM Pharmaceutical Co., Ltd. Expands Functional Skincare And Oral Care Product Portfolio CI
18-09-11 Km Pharmaceutical Co., Ltd. completed the acquisition of IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction. CI
18-08-01 IBKS No.3 Special Purpose Acquisition Company‘s Equity Buyback announced on March 1, 2018, has expired. CI
18-04-19 Sungkeun Mun acquired 4.9% stake in Km Pharmaceutical Co., Ltd. from K Investment Co., Ltd., Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73, and KTB Mezzanine Private Investment Trust No. 74, funds managed by KTB Asset Management Co., Ltd for KRW 2.7 billion. CI
18-04-19 Km Pharmaceutical Co., Ltd. cancelled the acquisition of 4% in Iconix Co., Ltd. from Wonjung Kim, Hyunsoo Seo, Changhwan Shin, Youngsik Im and Miyoung Jung. CI
18-03-01 Km Pharmaceutical Co., Ltd. announces an Equity Buyback. CI
18-02-27 Km Pharmaceutical Co., Ltd. authorizes a Buyback Plan. CI
18-02-27 Km Pharmaceutical Co., Ltd. entered into an agreement to acquire IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction. CI
1 day+2.35%
3 months-52.48%
6 months-73.00%
Current year-74.05%
Current year 508
Extreme 508
6,850
1 year 508
Extreme 508
6,850
3 years 508
Extreme 508
6,850
5 years 508
Extreme 508
13,250
10 years 508
Extreme 508
33,250
Manager TitleAgeSince
Chief Executive Officer 42 2022-03-27
Chief Executive Officer 58 2018-09-11
Corporate Officer/Principal 50 2018-09-11
Director TitleAgeSince
Chairman 58 2018-09-11
Director/Board Member 50 2018-09-11
Director/Board Member 42 -
Change 5-day change 1-year change 3-year change Capi.($)
+2.35%-.--%-77.34%-86.68% 2.93M
-0.61%+0.91%+4.55%+6.03% 369B
-1.50%+4.88%+12.78%+8.48% 255B
-2.05%-2.27%-8.75%+11.48% 140B
-0.52%-1.83%+18.86%+24.11% 73.48B
+0.11%+5.83%+32.57% - 52.06B
-0.12%-2.02%-27.71%-26.84% 44.97B
+0.89%+5.45%+10.68%-14.58% 39.2B
-0.51%+1.52%+33.22%+3.70% 37.32B
-0.64%+1.65%-10.16%-9.30% 36.28B
Average -0.22%+1.85%-1.13%-9.29% 104.77B
Weighted average by Cap. -0.85%+1.68%+6.53%+5.81%

Financials

2024 2025
Net sales 14.47B 10.77M 9.66M 8.93M 8.09M 15.11M 1.03B 15.3M 107M 42.54M 537M 40.41M 39.55M 1.7B 15.99B 11.89M 10.67M 9.87M 8.94M 16.69M 1.13B 16.9M 118M 46.99M 593M 44.64M 43.69M 1.88B
Net income -4.57B -3.4M -3.05M -2.82M -2.56M -4.77M -324M -4.83M -33.74M -13.44M -170M -12.77M -12.5M -538M -3.97B -2.95M -2.65M -2.45M -2.22M -4.14M -281M -4.19M -29.28M -11.66M -147M -11.08M -10.84M -467M
Net Debt 13.33B 9.91M 8.89M 8.22M 7.45M 13.91M 944M 14.08M 98.32M 39.16M 494M 37.2M 36.42M 1.57B 15.45B 11.49M 10.31M 9.53M 8.63M 16.13M 1.09B 16.33M 114M 45.4M 573M 43.13M 42.22M 1.82B
Projected Income Statement - Annual - KMPHARMACEUTICAL Co.,Ltd.
Logo KMPHARMACEUTICAL Co.,Ltd.
KMPharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of personal products. The Company is principally engaged in the manufacture and sale of oral hygiene products such as toothpaste, toothbrushes and gargles for children and adults. The Company is engaged in the manufacture and sale of beauty care products such as shampoo, body wash, cosmetics as well as other daily necessities. In addition, the Company is also engaged in the real estate leasing.
Employees
-
  1. Stock Market
  2. Stocks
  3. A225430 Stock